Post Cardiac Arrest Syndrome
9
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
TNF-α Antagonists Mitigate Systemic Inflammatory Response After Cardiac Arrest.
Hypothermia Versus Normothermia After Extracorporeal Cardiopulmonary Resuscitation for Out-of-hospital Cardiac Arrest
Intensive Care Unit Management After Cardiac ARrest in Russia
Lung-cOnservative Liquid VEntilation for the Induction of Ultra-Rapid COOLing After Cardiac Arrest
Steroid Treatment After Resuscitated Out-of-Hospital Cardiac Arrest
Post-Surgery Extracorporeal Life Support
Pre-hospital Post ROSC Care: Are we Achieving Our Targets?
Histones and Free-plasma DNA After Cardiac Arrest
The Complement Lectin Pathway After Cardiac Arrest